AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,988.00p
   
  • Change Today:
    -38.00p
  • 52 Week High: 12,144.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 1,636,659
  • Market Cap: £185,840m
  • RiskGrade: 123

Newspaper Links

Proxy advisory groups under fire after AstraZene... 15-Apr-2024 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian
AstraZeneca pours cash into research and develop... 07-Nov-2014 Daily Mail
AstraZeneca raises sales outlook as rival drugs ... 07-Nov-2014 The Independent
AstraZeneca shares fall as Obama thwarts tax inv... 24-Sep-2014 Guardian
As battle over AstraZeneca looms, one lab in Slo... 01-Sep-2014 Guardian
Round two: Window opens for Pfizer move on Astra... 26-Aug-2014 Daily Mail
Share hunter: Upbeat Pfizer looks like a healthy... 26-Aug-2014 Express & Star
THURSDAY MARKET CLOSE: AstraZeneca buyout back i... 22-Aug-2014 The Scotsman
MARKET REPORT: Pfizer in wings boosts Astra- Zen... 22-Aug-2014 Express & Star
Astrazeneca predict healthy sales 01-Aug-2014 Express & Star
AstraZeneca boosts its lung drugs power with $2b... 31-Jul-2014 Guardian
Astrazeneca restocks with Almirall asthma-drug d... 31-Jul-2014 Express & Star
Round two: Pfizer set to launch a second attempt... 30-Jul-2014 Daily Mail
Pfizer defends £69bn move for AstraZeneca 30-Jul-2014 Telegraph
Vince Cable rules out action on foreign bids six... 09-Jul-2014 The Independent

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,988.00p
Change Today -38.00p
% Change -0.32 %
52 Week High 12,144.00
52 Week Low 9,501.00
Volume 1,636,659
Shares Issued 1,550.22m
Market Cap £185,840m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average
92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average
Price Trend
57.75% above the market average57.75% above the market average57.75% above the market average57.75% above the market average57.75% above the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Income
87.48% below the market average87.48% below the market average87.48% below the market average87.48% below the market average87.48% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

What The Brokers Say

Strong Buy 8
Buy 13
Neutral 6
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 26-Apr-2024

Time Volume / Share Price
16:36 400 @ 11,988.00p
16:36 600 @ 11,988.00p
16:36 53,995 @ 11,976.12p
16:35 680,675 @ 11,988.00p
16:35 2,636 @ 11,988.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page